KalVista Pharmaceuticals, Ltd. Report issue

For profit Phase 2 Phase 3
Founded: Norton United Kingdom (2011)
Status: Acquired by Merck (2017)

Organization Overview

First Clinical Trial
2014
NCT02193113
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

KalVista Pharmaceuticals | KalVista Pharmaceuticals, Ltd.